Boji Medical Technology Co

Boji Medical Technology Co EBIT per Employee

The EBIT per Employee of Boji Medical Technology Co (300404.SZ) as of Nov 5, 2026 is 50,635.95 CNY. In the previous year, EBIT per Employee was 34,325.54 CNY — a change of 47.52% (higher).

EBIT per Employee

50,635.95CNY

YoY

47.52%

Last updated:

EBIT per Employee of Boji Medical Technology Co is 2025 50,635.95 CNY. EBIT per Employee of Boji Medical Technology Co was 2024 34,325.54 CNY. It decreases by 47.52% higher compared to the previous year.

The Boji Medical Technology Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
18,285.04 CNY
Jan 1, 2019
17,848.83 CNY
Jan 1, 2020
31,888.92 CNY
Jan 1, 2021
45,982.17 CNY
Jan 1, 2022
29,301.42 CNY
Jan 1, 2023
27,841.79 CNY
Jan 1, 2024
34,325.54 CNY
Jan 1, 2025
50,635.95 CNY
The Boji Medical Technology Co EBIT per Employee history
YEAREBIT per EmployeeYoY
50,635.95CNY+47.52%
34,325.54CNY+23.29%
27,841.79CNY-4.98%
29,301.42CNY-36.28%
45,982.17CNY+44.19%
31,888.92CNY+78.66%
17,848.83CNY-2.39%
18,285.04CNY-274.81%
-10,459.66CNY-28,884.45%
36.34CNY-99.82%
20,206.89CNY-44.21%
36,219.22CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boji Medical Technology Co Stock analysis

What does Boji Medical Technology Co do? Boji Medical Technology Co., Ltd. generates revenue through comprehensive CRO services for pharmaceutical and medical device development. The company offers preclinical research, clinical trials, data management, biostatistics, and regulatory consulting, primarily serving domestic pharmaceutical companies and research institutions. Their one-stop service model includes drug evaluation, medical device registration, and CDMO services for new drug and device production. The firm's domestic market focus ensures steady demand from local clients seeking regulatory compliance and R&D support. The company's revenue streams are derived from multiple service segments: preclinical studies, clinical research, and technology transfer. These services are tailored to meet the needs of pharmaceutical firms requiring outsourced R&D solutions. CDMO services further enhance their offerings by supporting manufacturing processes alongside development. Domestic clients form the core customer base, leveraging Boji's expertise in navigating China's regulatory landscape for drug and device approvals. Boji Medical Technology's business model centers on providing end-to-end CRO solutions, combining preclinical and clinical research with regulatory support. Their services are designed to accelerate product development cycles for clients, reducing time-to-market for new pharmaceuticals and medical devices. The firm's domestic market strategy aligns with the growing demand for R&D outsourcing within China's healthcare sector. Boji Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boji Medical Technology Co stock

EBIT per Employee of Boji Medical Technology Co is 50,635.95 CNY in 2025.

EBIT per Employee of Boji Medical Technology Co changed from 34,325.54 CNY to 50,635.95 CNY, representing a 47.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Boji Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Boji Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Boji Medical Technology Co

All Key Metrics — Boji Medical Technology Co